Author

Maria del Mar Llorente

Observed names: M. Llorente, Maria del Mar LLorente

Institution: Hospital General de Elda

Observed institutions: VA New Jersey Health Care System, Hospital General de Elda

OpenAlex ID: A5112267873

Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial

2017 · Jesus García-Donas, Albert Font, et al. · The Lancet Oncology · 49

Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program

2019 · J. Corral, M. Majem, et al. · Clinical & Translational Oncology · 42

Epithelial-to-Mesenchymal Transition Mediates Resistance to Maintenance Therapy with Vinflunine in Advanced Urothelial Cell Carcinoma

2021 · Albert Font, Vicenç Ruiz de Porras, et al. · Cancers · 5

Maintenance vinflunine post cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC): Preliminary analysis of a randomized placebo controlled phase II trial (MAJA trial)—SOGUG 2011-02.

2015 · Joaquim Bellmunt, Begona Perez Valderrama, et al. · Journal of Clinical Oncology · 5

Vinflunine maintenance therapy versus best supportive care after platinum combination in advanced bladder cancer: A phase II, randomized, open label, study (MAJA study, SOGUG 2011-02)—Interim analysis on safety.

2014 · Susana Hernando Polo, Aranzazu Gonzalez del Alba, et al. · Journal of Clinical Oncology · 5

Randomized, placebo-controlled phase II trial (MAJA): Efficacy results of maintenance vinflunine after cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC)—SOGUG 2011-02.

2016 · Albert Font, Begoña Perez-Valderrama, et al. · Journal of Clinical Oncology · 4

Phase II trial of docetaxel (D) and high-dose celecoxib (C) in patients (Pts) with hormone resistant prostate cancer (HRPC)

2004 · B. Kasimis, J. Cogswell, et al. · Journal of Clinical Oncology · 2

Phase Ib study of PTC299, a novel oral inhibitor of tumor VEGF expression, in patients with advanced cancer.

2010 · G. K. Schwartz, M. A. Dickson, et al. · Journal of Clinical Oncology · 1

P2.01-022 Nintedanib/Docetaxel Efficacy in Advanced Lung Adenocarcinoma Treated with 1L Chemotherapy/2L Immunotherapy in Nintedanib NPU

2017 · J. Corral, M. Majem, et al. · Journal of Thoracic Oncology

Excellent Response to Dual Her2 Targeted Therapy in a Patient with Advanced Colorectal Cancer in Fourth Line of Treatment

2016 · A. Juárez, M. Montero, et al. · Clinics in Oncology

Randomized placebo controlled phase II trial (MAJA): Efficacy results of maintenance vinflunine after cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC). SOGUG 2011-02

2016 · B. Pérez-Valderrama, A. Font, et al. · Annals of Oncology

Works count: 11

Citation count: 113

H-index: 5

I10-index: 2